unlicensed topical formulation applied to a corneal graft (the patient's third) to treat Candida duobushaemulonii is unlikely to cause hepatic problems, it's almost as if AI summaries are less reliable than actual humans
(, Thu 4 Jun 2026, 20:33, Reply)
not sure if that confirms or refutes my point.
(, Thu 4 Jun 2026, 20:35, Reply)
(, Thu 4 Jun 2026, 21:19, Reply)